Lakefront Biotherapeutics NV
LKFT
$27.22
-$0.21-0.77%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 06/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 2.41M | 16.63M | 910.49M | -120.02M | -120.02M |
| Total Depreciation and Amortization | 3.47M | -- | 42.85M | 41.44M | 41.44M |
| Total Amortization of Deferred Charges | -- | -- | 4.41M | -- | -- |
| Total Other Non-Cash Items | -37.04M | -120.69M | -12.71M | 22.08M | 22.08M |
| Change in Net Operating Assets | -7.76M | 9.10M | -1.00B | -66.96M | -66.96M |
| Cash from Operations | -38.92M | -94.96M | -55.25M | -123.46M | -123.46M |
| Capital Expenditure | -33.10K | -141.20K | -1.87M | -4.72M | -4.72M |
| Sale of Property, Plant, and Equipment | 1.24M | 1.51M | 449.30K | -- | -- |
| Cash Acquisitions | -837.35M | -- | -- | -- | -- |
| Divestitures | 2.02M | 2.69M | 1.89M | -25.19M | -25.19M |
| Other Investing Activities | 949.90M | 66.51M | 84.07M | 114.69M | 114.69M |
| Cash from Investing | 115.77M | 70.57M | 84.54M | 84.79M | 84.79M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1.07M | -510.00K | -405.00K | -600.00K | -600.00K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -2.87M | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -4.50M | -585.30K | -471.50K | -681.00K | -681.00K |
| Foreign Exchange rate Adjustments | 6.57M | 803.30K | -1.57M | -1.96M | -1.96M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 78.94M | -24.17M | 27.25M | -41.31M | -41.31M |